rs1542081
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003909.5(CPNE3):c.1120+1124T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0977 in 152,220 control chromosomes in the GnomAD database, including 988 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.098 ( 988 hom., cov: 31)
Consequence
CPNE3
NM_003909.5 intron
NM_003909.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.281
Publications
3 publications found
Genes affected
CPNE3 (HGNC:2316): (copine 3) Calcium-dependent membrane-binding proteins may regulate molecular events at the interface of the cell membrane and cytoplasm. This gene encodes a protein which contains two type II C2 domains in the amino-terminus and an A domain-like sequence in the carboxy-terminus. The A domain mediates interactions between integrins and extracellular ligands. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CPNE3 | NM_003909.5 | c.1120+1124T>C | intron_variant | Intron 14 of 16 | ENST00000517490.6 | NP_003900.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CPNE3 | ENST00000517490.6 | c.1120+1124T>C | intron_variant | Intron 14 of 16 | 1 | NM_003909.5 | ENSP00000477590.1 | |||
| CPNE3 | ENST00000614678.1 | n.706+1124T>C | intron_variant | Intron 4 of 6 | 1 | |||||
| CPNE3 | ENST00000517354.5 | n.437+1124T>C | intron_variant | Intron 4 of 4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0978 AC: 14877AN: 152102Hom.: 992 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
14877
AN:
152102
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0977 AC: 14875AN: 152220Hom.: 988 Cov.: 31 AF XY: 0.102 AC XY: 7575AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
14875
AN:
152220
Hom.:
Cov.:
31
AF XY:
AC XY:
7575
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
2294
AN:
41558
American (AMR)
AF:
AC:
1493
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
463
AN:
3468
East Asian (EAS)
AF:
AC:
1741
AN:
5170
South Asian (SAS)
AF:
AC:
951
AN:
4808
European-Finnish (FIN)
AF:
AC:
1112
AN:
10598
Middle Eastern (MID)
AF:
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6439
AN:
68012
Other (OTH)
AF:
AC:
284
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
667
1334
2000
2667
3334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.